Showing 26 - 50 out of 83 results
Neurosciences
Concussion
Neuropsychiatric Trajectories and Behavioral Health Outcomes Following Concussion in an Integrated Health System
Heart and Vascular
Heart Failure
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
Heart and Vascular
Women's Cardiovascular Health
Monitoring outcomes for multidisciplinary care of women with cardiac disease in pregnancy: Creating a Cardio-Obstetrics Outcomes Log (COOL)
Heart and Vascular
Cardiometabolic
Phase 1b Randomized, Double-Blind, Placebo-Controlled Study of COR-1389 on Cardiopulmonary Hemodynamics in Patients with Pulmonary Hypertension Associated with Left-Heart Disease (PH-LHD)
Heart and Vascular
Myocardial Ischemia
Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II (COSIRA-II)
Heart and Vascular
Cardiothoracic Surgery | Ischemic Stroke
EMBOLIC PROTECTION IN PATIENTS UNDERGOING HIGH RISK VALVE SURGERY
Cancer
Breast Cancer
Phase 3 open label study comparing efficacy and safety of the combination of lasofoxifene and abemaciclib to the combination of fulvestrant and abemaciclib for the treatment of adults with locally advanced or metastatic ER+/HER2- breast cancer with an ESR1 mutation
Audiology | Cochlear Implant
A pivotal, pre-market, prospective, interventional, multicenter study to evaluate clinical benefit, performance, and safety of the TI1132 implant in an adult population with sensorineural hearing loss
Heart and Vascular
Heart Failure
Randomized trial of ELEVATEd cardiac pacing rate for personalized treatment of Heart Failure with preserved Ejection Fraction (ELEVATEHFpEF)
Heart and Vascular
Interventional Cardiology
THE MAGENTA ELEVATE™ HIGH-RISK PCI PIVOTAL STUDY
Cancer
Breast Cancer
A Phase 3, randomized, open-label, multicenter, controlled study to evaluate the efficacy and safety of zanidatamab in combination with physician’s choice chemotherapy compared to trastuzumab in combination with physician’s choice chemotherapy for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous trastuzumab deruxtecan treatment
Heart and Vascular
Aortic Stenosis
Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients who have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement
Cancer
Breast Cancer
Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease
Heart and Vascular
Valvular Diseases
Explanted Heart Valve Registry
Heart and Vascular
Heart Failure
A randomized, double-blind, placebo-controlled pragmatic study to evaluate FINerenone on clinicAL effIcacy and safeTY in patients with Heart Failure and reduced ejection fraction who are intolerant of or not eligible for treatment with steroidal mineralocorticoid receptor antagonists
Pulmonology
Lung Cancer
A Multicenter Randomized Trial of EBUS-TBNA Versus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing
Neurosciences
Neurology
Vivistim Registry for Paired VNS Therapy (GRASP)
Heart and Vascular
Women's Cardiovascular Health | Pregnancy
Heart Outcomes in Pregnancy Expectations (HOPE) for Mom and Baby
Cancer
Breast Cancer
A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations
Heart and Vascular
Structural | Endocarditis
INFECTIVE ENDOCARDITIS IN ADULTS WITH CONGENITAL HEART DISEASE: A REGISTRY
Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Heart and Vascular
Women's Cardiovascular Health
iSCAD Registry
Cancer
Breast Cancer
A Randomized, Open-label, Inferentially Seamless Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer (TNBC) or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment
Heart and Vascular
Amyloidosis
A Non-interventional, Prospective, Multi-country Study Collecting Realworld Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis
Heart and Vascular
Cardiometabolic
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Saint Luke's is committed to improving your experience. If you have questions, please call Saint Luke's Concierge at 816-932-5100, Monday–Friday, 7 a.m.–5 p.m. In case of emergency please call 911.